Anti-inflammatory androstane derivative compositions
US6777400B2 · kind B2 · utility
31Cited by
40References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 11, 2002 |
| Grant date | Aug 17, 2004 |
| Priority date | — |
| Expiry date | Oct 3, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There is provided a crystalline chemical composition comprising a compound of formula (I) in which the crystal lattice is stabilised by the presence of a guest molecule, characterised in the crystalline composition is of space group P212121 having unit cell dimensions of about 7.6±0.6 å, 12.7±0.7 å, and 33±3 å when determined at 120K.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.